MLXIPL and hepatocellular carcinoma: Finally, to confirm that ChREBP represents an interesting target to treat HCC, tumor development was induced by treating WT and liver-specific ChREBP KO mice with a combination of the carcinogen diethylnitrosamine (DEN) with the carbon-tetrachloride (CCl4) hepatotoxin.